Advertisement

Neurourology pp 525-532 | Cite as

Spinal Cord Injury

  • Hazel Ecclestone
  • Rizwan Hamid
Chapter

Abstract

Spinal cord injury (SCI) is a sudden devastating life-changing event. This may be a consequence of trauma, infection, vascular or iatrogenic injury. Once the acute phase is over, neurological consequences are usually stable and persist lifelong. The severity of SCI is reflected in the degree of paralysis and sensation loss as well as the (in)ability to perform activities of daily living, and is classified by the American Spinal Injury Association (ASIA) impairment scale [1].

References

  1. 1.
    Ditunno JF, Young W, Donovan WH, et al. The international standards booklet for neurological and functional classification of spinal cord injury. Spinal Cord. 1994;32:70–80.CrossRefGoogle Scholar
  2. 2.
    McColl MA, Walker J, Stirling P, et al. Expectations of life and health among spinal cord injured adults. Spinal Cord. 1997;35:818–28.CrossRefGoogle Scholar
  3. 3.
    Garshick E, Kelley A, Cohen SA, et al. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord. 2005;43:408–16.CrossRefGoogle Scholar
  4. 4.
    Jackson AB, Dijkers M, DeVivo MJ, et al. A demographic profile of new traumatic spinal cord injuries: change and stability over 30 years. Arch Phys Med Rehabil. 2004;85:1740–8.CrossRefGoogle Scholar
  5. 5.
    Alexander MS, Biering-Sorensen F, Bodner D, et al. International standards to document remaining autonomic function after spinal cord injury. Spinal Cord. 2009;47:36–43.CrossRefGoogle Scholar
  6. 6.
    Ditunno JF, Little JW, Tessler A, et al. Spinal shock revisited: a four-phase model. Spinal Cord. 2004;42:383–95.CrossRefGoogle Scholar
  7. 7.
    Ethans KD, Casey AR, Bard RJ, et al. Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA. Degener Neurol Neuromuscul Dis. 2014;4:65–73.Google Scholar
  8. 8.
    Norris JP, Staskin DR. History, physical examination, and classification of neurogenic voiding dysfunction. Urol Clin North Am. 1996;23:337–44.CrossRefGoogle Scholar
  9. 9.
    Moslavac S, Dzidic I, Kejla Z. Neurogenic detrusor overactivity: comparison between complete and incomplete spinal cord injury patients. Neurourol Urodyn. 2008;27:504–6.CrossRefGoogle Scholar
  10. 10.
    Curt A, Nitsche B, Rodic B, et al. Assessment of autonomic dysreflexia in patients with spinal cord injury. J Neurol Neurosurg Psychiatry. 1997;62:473–7.CrossRefGoogle Scholar
  11. 11.
    Itorai I, Kim R, Vulpe M, et al. Fatal cerebral hemorrhage due to autonomic dysreflexia in a tetraplegic patient: case report and review. Paraplegia. 1992;30:355–60.Google Scholar
  12. 12.
    Weld KJ, Graney MJ, Dmochowski RR. Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients. J Urol. 2000;163:1228–33.CrossRefGoogle Scholar
  13. 13.
    Blok B, Pannek J, Castro-Diaz D, et al. EAU guidelines on neuro-urology. 2016. http://uroweb.org/guideline/neuro-urology/.
  14. 14.
    Consortium for Spianl Cord. Acute management of autonomic dysreflexia: adults with spinal cord injury presenting to health-care facilities. J Spinal Cord Med. 1997;20:284–308.CrossRefGoogle Scholar
  15. 15.
    Costa P, Perrouin-Verbe B, Colvez A, et al. Quality of life in spinal cord injury pateints with urinary difficulties. Development and validation of qualiveen. Eur Urol. 2001;39:107–13.CrossRefGoogle Scholar
  16. 16.
    NICE. Urinary incontinence in neurological disease: assessment and management. Clinical guideline [CG148]. https://www.nice.org.uk/guidance/CG148/chapter/1-Guidance#monitoring-and-surveillance-protocols. Accessed 3 Sept 2017.
  17. 17.
    Lawrenson R, Wyndalaele JJ, Vlachonikolis I, et al. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology. 2001;20:38–43.CrossRefGoogle Scholar
  18. 18.
    Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol. 2000;163:768–72.CrossRefGoogle Scholar
  19. 19.
    Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? Urology. 2002;59:240–4.CrossRefGoogle Scholar
  20. 20.
    Kaufman JM, Fam B, Jacobs SC, et al. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol. 1977;118:967–71.CrossRefGoogle Scholar
  21. 21.
    Spinal Cord Medicine Consortium. Clinical practice guidelines: neurogenic bowel management in adults with spinal cord injury. J Spinal Cord Med. 1998;21:248–93.CrossRefGoogle Scholar
  22. 22.
    Christensen P, Bazzocchi G, Coggrave M, et al. A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord–injured patients. Gastroenterology. 2006;131:738–47.CrossRefGoogle Scholar
  23. 23.
    Levi R, Hultling C, Nash MS, et al. The Stockholm spinal cord injury study: 1. Medical problems in a regional SCI population. Paraplegia. 1995;33:308–15.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Giuliano F, Hultling C, El Masry WS, et al. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Ann Neurol. 1999;46:15–21.CrossRefGoogle Scholar
  25. 25.
    Deforge D, Blackmer J, Garritty C, et al. Male erectile dysfunction following spinal cord injury: a systematic review. Spinal Cord. 2006;44:465–73.CrossRefGoogle Scholar
  26. 26.
    DeForge D, Blackmer J, Garritty C, et al. Fertility following spinal cord injury: a systematic review. Spinal Cord. 2005;43:693–703.CrossRefGoogle Scholar
  27. 27.
    Sipski ML, Alexander CJ, Rosen R. Sexual arousal and orgasm in women: effects of spinal cord injury. Ann Neurol. 2001;49:35–44.CrossRefGoogle Scholar
  28. 28.
    Chancellor MB, Anderson RU, Boone TB. Pharmacotherapy for neurogenic detrusor overactivity. Am J Phys Med Rehabil. 2006;85:536–45.CrossRefGoogle Scholar
  29. 29.
    Buyse G, Waldeck K, Verpoorten C, et al. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol. 1998;160:892–6.CrossRefGoogle Scholar
  30. 30.
    Shohrer M, Pannek J. Surgery to improve reservoir function. In: Corcos J, Schick E, editors. Textbook of the neuropathic bladder. 2nd ed. London: Informa Healthcare; 2008. p. 634–41.Google Scholar
  31. 31.
    Perrouin-Verbe B, Labat JJ, Richard I, et al. Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Paraplegia. 1995;33:619–24.PubMedGoogle Scholar
  32. 32.
    Talbot HS, Mahony EM, Jaffee SR. The effect of prolonged urethral catheterization: I. Persistence of normal renal structure and function. J Urol. 1959;81:138–43.CrossRefGoogle Scholar
  33. 33.
    Hamid R, Bycroft J, Arya M, et al. Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: is it valid? J Urol. 2003;170:425–7.CrossRefGoogle Scholar
  34. 34.
    McClurg D, Ashe RG, Marshall K, et al. Comparison of pelvic floor muscle training, electromyography, biofeedback and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomised pilot study. Neurourol Urodyn. 2006;25:337–48.CrossRefGoogle Scholar
  35. 35.
    Schurch B, Schmid DM, Stöhrer M. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med. 2000;342:665.CrossRefGoogle Scholar
  36. 36.
    Haferkamp A, Schurch B, Reitz A, et al. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder. Eur Urol. 2004;46:784–91.CrossRefGoogle Scholar
  37. 37.
    Del Popolo G, Filocamo MT, Li Marzi V, et al. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre. Eur Urol. 2008;53:1013–9.CrossRefGoogle Scholar
  38. 38.
    Cruz F, Herschorn S, Aliotta P, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2011;60:742–50.CrossRefGoogle Scholar
  39. 39.
    Khastgir J, Hamid R, Arya M, et al. Surgical and patient reported outcomes of ‘clam’ augmentation ileocystoplasty in spinal cord injured patients. Eur Urol. 2003;43:263–9.CrossRefGoogle Scholar
  40. 40.
    Greenwell TJ, Venn SN, Mundy AR. Augmentation cystoplasty. BJU Int. 2001;88:511–25.CrossRefGoogle Scholar
  41. 41.
    Leng WW, Blalock HJ, Fredriksson WH, et al. Enterocystoplasty or detrusor myomectomy? Comparison of indications and outcomes for bladder augmentation. J Urol. 1999;161:758–63.CrossRefGoogle Scholar
  42. 42.
    Bennett JK, Green BG, Foote JE, et al. Collagen injections for intrinsic sphincter deficiency in the neuropathic urethra. Paraplegia. 1995;33:697–700.PubMedGoogle Scholar
  43. 43.
    Hamid R, Arya M, Khastgir J, et al. The treatment of male stress urinary incontinence with polydimethylsiloxane in compliant bladders following spinal cord injury. Spinal Cord. 2003;41:286–9.CrossRefGoogle Scholar
  44. 44.
    Decter RM. Use of the fascial sling for neurogenic incontinence: lessons learned. J Urol. 1993;150:683–6.CrossRefGoogle Scholar
  45. 45.
    Abdul-Rahman A, Attar KH, Hamid R, et al. Long-term outcome of tension-free vaginal tape for treating stress incontinence in women with neuropathic bladders. BJU Int. 2010;106:827–30.CrossRefGoogle Scholar
  46. 46.
    Kastler EC, Genevois S, et al. Treatment of neurogenic male urinary incontinence related to intrinsic sphincter insufficiency with an artificial urinary sphincter: a French retrospective multicentre study. BJU Int. 2011;107:426–32.CrossRefGoogle Scholar
  47. 47.
    Patki P, Hamid R, Shah PJ, et al. Long-term efficacy of AMS 800 artificial urinary sphincter in male patients with urodynamic stress incontinence due to spinal cord lesion. Spinal Cord. 2006;44:297–300.CrossRefGoogle Scholar
  48. 48.
    Chancellor MB, Erhard MJ, Kiilholma PJ, et al. Functional urethral closure with pubovaginal sling for destroyed female urethra after long-term urethral catheterization. Urology. 1994;43:499–505.CrossRefGoogle Scholar
  49. 49.
    Zimmern PE, Hadley HR, Leach GE, et al. Transvaginal closure of the bladder neck and placement of a suprapubic catheter for destroyed urethra after long-term indwelling catheterization. J Urol. 1985;134:554–7.CrossRefGoogle Scholar
  50. 50.
    Brindley GS. An implant to empty the bladder or close the urethra. J Neurol Neurosurg Psychiatry. 1977;40:358–69.CrossRefGoogle Scholar
  51. 51.
    Schurch B, Rodic B, Jeanmonod D. Posterior sacral rhizotomy and intradural anterior sacral root stimulation for treatment of the spastic bladder in spinal cord injured patients. J Urol. 1997;157:610–4.CrossRefGoogle Scholar
  52. 52.
    Schmidt RA, Tanagho EA. Feasibility of controlled micturition through electric stimulation. Urol Int. 1979;34:199–230.CrossRefGoogle Scholar
  53. 53.
    Braun PM, Baezner H, Seif C, et al. Alterations of cortical electrical activity in patients with sacral neuromodulator. Eur Urol. 2002;41:562–6.CrossRefGoogle Scholar
  54. 54.
    Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010;58:865–74.CrossRefGoogle Scholar
  55. 55.
    Kaplan SA, Chancellor MB, Blaivas JG. Bladder and sphincter behaviour in patients with spinal cord injury. J Urol. 1991;146:113.CrossRefGoogle Scholar
  56. 56.
    Stöhrer M, Kramer G, Löchner-Ernst D, et al. Diagnosis and treatment of bladder dysfunction in spinal cord injury patients. Eur Urol Update Series. 1994;3:170–5.Google Scholar
  57. 57.
    Seoane-Rodríguez S, Sánchez R-Losada J, Montoto-Marqués A, et al. Long-term follow-up study of intraurethral stents in spinal cord injured patients with detrusor-sphincter dyssynergia. Spinal Cord. 2007;45:621–6.CrossRefGoogle Scholar
  58. 58.
    Hamid R, Arya M, Patel HR, et al. The mesh wallstent in the treatment of detrusor external sphincter dyssynergia in men with spinal cord injury: a 12-year follow-up. BJU Int. 2003;91:51–3.CrossRefGoogle Scholar
  59. 59.
    Phelan MW, Franks M, Somogyi GT, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol. 2001;165:1107–10.CrossRefGoogle Scholar
  60. 60.
    Liard A, Séquier-Lipszyc E, Mathiot A, et al. The Mitrofanoff procedure: 20 years later. J Urol. 2001;165:2394–8.CrossRefGoogle Scholar
  61. 61.
    Sylora JA, Gonzalez R, Vaughn M, et al. Intermittent self-catheterization by quadriplegic patients via a catheterizable Mitrofanoff channel. J Urol. 1997;157:48–50.CrossRefGoogle Scholar
  62. 62.
    Castro-Diaz D, Barrett D, Grise P, et al. Surgery for the neuropathic patient. In: Abrams P, Khoury S, Wein A, editors. Incontinence. 2nd ed. Plymouth: Health Publication; 2002. p. 865–91.Google Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Hazel Ecclestone
    • 1
  • Rizwan Hamid
    • 2
  1. 1.University College London HospitalsLondonUK
  2. 2.London Spinal Injuries UnitStanmore & University College London HospitalsLondonUK

Personalised recommendations